Literature DB >> 20664014

Recommended guidelines for the conduct and evaluation of prognostic studies in veterinary oncology.

J D Webster1, M M Dennis, N Dervisis, J Heller, N J Bacon, P J Bergman, D Bienzle, G Cassali, M Castagnaro, J Cullen, D G Esplin, L Peña, M H Goldschmidt, K A Hahn, C J Henry, E Hellmén, D Kamstock, J Kirpensteijn, B E Kitchell, R L Amorim, S D Lenz, T P Lipscomb, M McEntee, L D McGill, C A McKnight, P M McManus, A S Moore, P F Moore, S D Moroff, H Nakayama, N C Northrup, G Sarli, T Scase, K Sorenmo, F Y Schulman, A M Shoieb, R C Smedley, W L Spangler, E Teske, D H Thamm, V E Valli, W Vernau, H von Euler, S J Withrow, S E Weisbrode, J Yager, M Kiupel.   

Abstract

There is an increasing need for more accurate prognostic and predictive markers in veterinary oncology because of an increasing number of treatment options, the increased financial costs associated with treatment, and the emotional stress experienced by owners in association with the disease and its treatment. Numerous studies have evaluated potential prognostic and predictive markers for veterinary neoplastic diseases, but there are no established guidelines or standards for the conduct and reporting of prognostic studies in veterinary medicine. This lack of standardization has made the evaluation and comparison of studies difficult. Most important, translating these results to clinical applications is problematic. To address this issue, the American College of Veterinary Pathologists' Oncology Committee organized an initiative to establish guidelines for the conduct and reporting of prognostic studies in veterinary oncology. The goal of this initiative is to increase the quality and standardization of veterinary prognostic studies to facilitate independent evaluation, validation, comparison, and implementation of study results. This article represents a consensus statement on the conduct and reporting of prognostic studies in veterinary oncology from veterinary pathologists and oncologists from around the world. These guidelines should be considered a recommendation based on the current state of knowledge in the field, and they will need to be continually reevaluated and revised as the field of veterinary oncology continues to progress. As mentioned, these guidelines were developed through an initiative of the American College of Veterinary Pathologists' Oncology Committee, and they have been reviewed and endorsed by the World Small Animal Veterinary Association.

Entities:  

Mesh:

Year:  2010        PMID: 20664014     DOI: 10.1177/0300985810377187

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  12 in total

Review 1.  Treatment of Canine Oral Melanomas: A Critical Review of the Literature.

Authors:  Paolo Pazzi; Gerhard Steenkamp; Anouska J Rixon
Journal:  Vet Sci       Date:  2022-04-19

Review 2.  The role of COX expression in the prognostication of overall survival of canine and feline cancer: A systematic review.

Authors:  Hugo Gregório; Tomás R Magalhães; Isabel Pires; Justina Prada; Maria I Carvalho; Felisbina L Queiroga
Journal:  Vet Med Sci       Date:  2021-03-10

3.  CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade.

Authors:  Elisabetta Manuali; Antonio De Giuseppe; Francesco Feliziani; Katia Forti; Cristina Casciari; Maria Chiara Marchesi; Eugenio Pacifico; Karol M Pawłowski; Kinga Majchrzak; Magdalena Król
Journal:  BMC Vet Res       Date:  2012-06-22       Impact factor: 2.741

Review 4.  Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting.

Authors:  Gary S Collins; Susan Mallett; Omar Omar; Ly-Mee Yu
Journal:  BMC Med       Date:  2011-09-08       Impact factor: 8.775

5.  Dissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphoma.

Authors:  Dammy Pinheiro; Yu-Mei Chang; Hannah Bryant; Balazs Szladovits; Tim Dalessandri; Lucy J Davison; Elizabeth Yallop; Emily Mills; Chiara Leo; Ana Lara; Anneliese Stell; Gerry Polton; Oliver A Garden
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

6.  Prognostic Markers in Acute Babesia canis Infections.

Authors:  R M Eichenberger; B Riond; B Willi; R Hofmann-Lehmann; P Deplazes
Journal:  J Vet Intern Med       Date:  2016-01-04       Impact factor: 3.333

7.  Veterinary Pathology - A Path Forward with New Directions and Opportunities.

Authors:  Tracy Stokol
Journal:  Front Vet Sci       Date:  2016-08-31

8.  A Prognostic Model for the Outcome of Nobel Biocare Dental Implants with Peri-Implant Disease after One Year.

Authors:  Miguel de Araújo Nobre; Francisco Salvado; Paulo Nogueira; Evangelista Rocha; Peter Ilg; Paulo Maló
Journal:  J Clin Med       Date:  2019-09-01       Impact factor: 4.241

9.  Evidence supporting the conceptual framework of cancer chemoprevention in canines.

Authors:  Tamara P Kondratyuk; Julie Ann Luiz Adrian; Brian Wright; Eun-Jung Park; Richard B van Breemen; Kenneth R Morris; John M Pezzuto
Journal:  Sci Rep       Date:  2016-05-24       Impact factor: 4.379

10.  Systematic review of guidelines for internal validity in the design, conduct and analysis of preclinical biomedical experiments involving laboratory animals.

Authors:  Jan Vollert; Esther Schenker; Malcolm Macleod; Anton Bespalov; Hanno Wuerbel; Martin Michel; Ulrich Dirnagl; Heidrun Potschka; Ann-Marie Waldron; Kimberley Wever; Thomas Steckler; Tom van de Casteele; Bruce Altevogt; Annesha Sil; Andrew S C Rice
Journal:  BMJ Open Sci       Date:  2020-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.